Related references
Note: Only part of the references are listed.Bacterial Coinfection in COVID-19
Michael Proschan et al.
CLINICAL INFECTIOUS DISEASES (2021)
Utilizing Bayesian predictive power in clinical trial design
Ofir Harari et al.
PHARMACEUTICAL STATISTICS (2021)
Comparison of Bayesian and frequentist group-sequential clinical trial designs
Nigel Stallard et al.
BMC MEDICAL RESEARCH METHODOLOGY (2020)
Resist the Temptation of Response-Adaptive Randomization
Michael Proschan et al.
CLINICAL INFECTIOUS DISEASES (2020)
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
Brett L. Houston et al.
CLINICAL TRIALS (2020)
A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method
Bernard North et al.
BMC CANCER (2019)
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial
Karen C. Johnston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
When to keep it simple - adaptive designs are not always useful
James M. S. Wason et al.
BMC MEDICINE (2019)
Adaptive platform trials: definition, design, conduct and reporting considerations The Adaptive Platform Trials Coalition
Derek C. Angus et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma
Akihiro Hirakawa et al.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2018)
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
Natalie Cook et al.
BRITISH JOURNAL OF CANCER (2018)
Accuracy, Safety, and Reliability of Novel Phase I Trial Designs
Heng Zhou et al.
CLINICAL CANCER RESEARCH (2018)
Arguing for Adaptive Clinical Trials in Sepsis
Victor B. Talisa et al.
FRONTIERS IN IMMUNOLOGY (2018)
Rationale and design of the Study To Understand Fall Reduction and Vitamin D in You (STURDY): A randomized clinical trial of Vitamin D supplement doses for the prevention of falls in older adults
Erin D. Michos et al.
CONTEMPORARY CLINICAL TRIALS (2018)
Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research
W. Charles Huskins et al.
CLINICAL INFECTIOUS DISEASES (2018)
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
Brian M. Alexander et al.
CLINICAL CANCER RESEARCH (2018)
Results and evaluation of a first-in-human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods
Stefan Sturm et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Bayesian optimal experimental designs for binary responses in an adaptive framework
Alessandra Giovagnoli
APPLIED STOCHASTIC MODELS IN BUSINESS AND INDUSTRY (2017)
A Bayesian response-adaptive trial in tuberculosis: The endTB trial
Matteo Cellamare et al.
CLINICAL TRIALS (2017)
Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment
Alexina J. Mason et al.
STATISTICS IN MEDICINE (2017)
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study
Patricia Murphy et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2017)
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Edward L. Korn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial)
Miroslav Backonja et al.
PAIN (2017)
Bayesian doubly adaptive randomization in clinical trials
YiKe Xiao et al.
SCIENCE CHINA-MATHEMATICS (2017)
Adaptive Clinical Trials: Advantages and Disadvantages of Various Adaptive Design Elements
Edward L. Korn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
A simulation study of outcome adaptive randomization in multi-arm clinical trials
J. Kyle Wathen et al.
CLINICAL TRIALS (2017)
Combining Bayesian experimental designs and frequentist data analyses: motivations and examples
Steffen Ventz et al.
APPLIED STOCHASTIC MODELS IN BUSINESS AND INDUSTRY (2017)
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma
Scott M. Schuetze et al.
CANCER (2016)
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Vassiliki Papadimitrakopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adaptive Randomization of Neratinib in Early Breast Cancer
J. W. Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
I-SPY 2-Toward More Rapid Progress in Breast Cancer Treatment
Lisa A. Carey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer
H. S. Rugo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug development
Kaspar Rufibach et al.
PHARMACEUTICAL STATISTICS (2016)
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
Alexandra R. Brown et al.
TRIALS (2016)
Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials
P. Thall et al.
ANNALS OF ONCOLOGY (2015)
Are outcome-adaptive allocation trials ethical?
Spencer Phillips Hey et al.
CLINICAL TRIALS (2015)
The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study
Jason T. Connor et al.
TRIALS (2015)
A practical guide to Bayesian group sequential designs
Thomas Gsponer et al.
PHARMACEUTICAL STATISTICS (2014)
A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
James M. S. Wason et al.
STATISTICS IN MEDICINE (2014)
A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials
Wei Zhong et al.
CONTEMPORARY CLINICAL TRIALS (2013)
On Recent Advances in Optimal Allocation Designs in Clinical Trials
Oleksandr Sverdlov et al.
JOURNAL OF STATISTICAL THEORY AND PRACTICE (2013)
Worth Adapting? Revisiting the Usefulness of Outcome-Adaptive Randomization
J. Jack Lee et al.
CLINICAL CANCER RESEARCH (2012)
Adaptive Bayesian compound designs for dose finding studies
J. M. McGree et al.
JOURNAL OF STATISTICAL PLANNING AND INFERENCE (2012)
Phase II trial design with Bayesian adaptive randomization and predictive probability
Guosheng Yin et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2012)
Adaptive clinical trials in oncology
Donald A. Berry
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Celebrating 70: An Interview with Don Berry
Dalene Stangl et al.
STATISTICAL SCIENCE (2012)
Bayesian adaptive clinical trials: a dream for statisticians only?
Sylvie Chevret
STATISTICS IN MEDICINE (2012)
Bayesian clinical trials in action
J. Jack Lee et al.
STATISTICS IN MEDICINE (2012)
A BAYESIAN METHOD FOR THE CHOICE OF THE SAMPLE SIZE IN EQUIVALENCE TRIALS
Stefania Gubbiotti et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF STATISTICS (2011)
Adaptive Clinical Trials: The Promise and the Caution
Donald A. Berry
JOURNAL OF CLINICAL ONCOLOGY (2011)
On the Usefulness of Outcome-Adaptive Randomization
Ying Yuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Outcome-Adaptive Randomization: Is It Useful?
Edward L. Korn et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Bayesian response-adaptive covariate-balanced randomization design with application to a leukemia clinical trial
Ying Yuan et al.
STATISTICS IN MEDICINE (2011)
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim et al.
CANCER DISCOVERY (2011)
SEQUENTIAL MONITORING OF RESPONSE-ADAPTIVE RANDOMIZED CLINICAL TRIALS
Hongjian Zhu et al.
ANNALS OF STATISTICS (2010)
Compound optimal allocation for individual and collective ethics in binary clinical trials
Alessandro Baldi Antognini et al.
BIOMETRIKA (2010)
A modified toxicity probability interval method for dose-finding trials
Yuan Ji et al.
CLINICAL TRIALS (2010)
Continual Reassessment and Related Dose-Finding Designs
John O'Quigley et al.
STATISTICAL SCIENCE (2010)
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
A. D. Barker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Bayesian clinical trials: no more excuses
Mithat Gonen
CLINICAL TRIALS (2009)
Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center
Swati Biswas et al.
CLINICAL TRIALS (2009)
A predictive probability design for phase II cancer clinical trials
J. Lack Lee et al.
CLINICAL TRIALS (2008)
Practical Bayesian adaptive randomisation in clinical trials
Peter F. Thall et al.
EUROPEAN JOURNAL OF CANCER (2007)
Sample size reestimation by Bayesian prediction
Ming-Dauh Wang
BIOMETRICAL JOURNAL (2007)
Bayesian statistics in medicine: A 25 year review
Deborah Ashby
STATISTICS IN MEDICINE (2006)
Bayesian clinical trials
DA Berry
NATURE REVIEWS DRUG DISCOVERY (2006)
A review of methods for futility stopping based on conditional power
JM Lachin
STATISTICS IN MEDICINE (2005)
Bayesian adaptive biased-coin designs for clinical trials with normal responses
AC Atkinson et al.
BIOMETRICS (2005)
Bayesian optimal designs for phase I clinical trials
LM Haines et al.
BIOMETRICS (2003)
Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN) - An adaptive dose-response study of UK-279,276 in acute ischemic stroke
M Krams et al.
STROKE (2003)
Adaptive decision making in a lymphocyte infusion trial
PF Thall et al.
BIOMETRICS (2002)
Patient specific dosing in a cancer phase I clinical trial
JS Babb et al.
STATISTICS IN MEDICINE (2001)
Share Paper
